UCB's Global Corporate Website
Welcome to UCB in the United States

Newsroom

Find U.S. news and updates from UCB, a global biopharmaceutical company focused on creating value for people living with severe diseases, such as epilepsy, Parkinson’s disease, psoriasis, osteoporosis, myasthenia gravis,  rheumatoid arthritis, psoriatic arthritis, non-radiographic axial spondyloarthritis, and more. 

Spotlight Story

My Commitment to the Newly Diagnosed and All People Living with Myasthenia Gravis

 

 

UCB U.S. News

UCB: A place where we can all be our authentic selves

Read More

UCB Builds Partnerships with Rare Epilepsy Syndrome Patient Groups

Read More

Disease Spotlight: Hidradenitis Suppurativa

Read More

Twitter Feed

For More Information